undefined cover
undefined cover
Episode #1 - Eliška Kuchovská cover
Episode #1 - Eliška Kuchovská cover
EUROTOX IN2TOX podcast

Episode #1 - Eliška Kuchovská

Episode #1 - Eliška Kuchovská

30min |13/04/2023
Play
undefined cover
undefined cover
Episode #1 - Eliška Kuchovská cover
Episode #1 - Eliška Kuchovská cover
EUROTOX IN2TOX podcast

Episode #1 - Eliška Kuchovská

Episode #1 - Eliška Kuchovská

30min |13/04/2023
Play

Description

Eliška Kuchovská, postdoctoral researcher at the Leibniz
Research Institute for Environmental Medicine, transports us into the world of
developmental neurotoxicology. In this episode we learn about the difficulties
of studying the effect of chemicals on brain development and why quantitative
adverse outcome pathways and physiological maps can help.   


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Description

Eliška Kuchovská, postdoctoral researcher at the Leibniz
Research Institute for Environmental Medicine, transports us into the world of
developmental neurotoxicology. In this episode we learn about the difficulties
of studying the effect of chemicals on brain development and why quantitative
adverse outcome pathways and physiological maps can help.   


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Share

Embed

You may also like

Description

Eliška Kuchovská, postdoctoral researcher at the Leibniz
Research Institute for Environmental Medicine, transports us into the world of
developmental neurotoxicology. In this episode we learn about the difficulties
of studying the effect of chemicals on brain development and why quantitative
adverse outcome pathways and physiological maps can help.   


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Description

Eliška Kuchovská, postdoctoral researcher at the Leibniz
Research Institute for Environmental Medicine, transports us into the world of
developmental neurotoxicology. In this episode we learn about the difficulties
of studying the effect of chemicals on brain development and why quantitative
adverse outcome pathways and physiological maps can help.   


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Share

Embed

You may also like